Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study | Zendy

Rima McLeod | Zendy; K. M. Boyer | Zendy; Theodore Karrison | Zendy; Kristen Kasza | Zendy; Charles N. Swisher | Zendy; Nancy Roizen | Zendy; Jessica Jalbrzikowski | Zendy; J. Remington | Zendy; Peter Heydemann | Zendy; A. Gwendolyn Noble | Zendy; M B Mets | Zendy; Ellen Holfels | Zendy; Shawn Withers | Zendy; Paul Latkany | Zendy; Petra Meier | Zendy

Open Access

Outcome of Treatment for Congenital Toxoplasmosis, 1981-2004: The National Collaborative Chicago-Based, Congenital Toxoplasmosis Study

Author(s) -

Rima McLeod,

K. M. Boyer,

Theodore Karrison,

Kristen Kasza,

Charles N. Swisher,

Nancy Roizen,

Jessica Jalbrzikowski,

J. Remington,

Peter Heydemann,

A. Gwendolyn Noble,

M B Mets,

Ellen Holfels,

Shawn Withers,

Paul Latkany,

Petra Meier

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/501360

Subject(s) - medicine , pyrimethamine , sulfadiazine , pediatrics , toxoplasmosis , hearing loss , pregnancy , disease , chorioretinitis , surgery , antibiotics , immunology , malaria , audiology , chloroquine , genetics , ophthalmology , microbiology and biotechnology , biology

Without treatment, congenital toxoplasmosis has recurrent, recrudescent, adverse outcomes. Long-term follow-up of infants with congenital toxoplasmosis treated throughout their first year of life with pyrimethamine and sulfadiazine has not been reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research